PHFI's K Srinath Reddy on the new Covid-variant and booster shots of vaccine

As the Omicron-variant of Covid-19 continues to rattle the world, health experts in India are grappling with its mutation data and the possibility of evading vaccine-induced immunity. Business Standard’s Ishaan Gera spoke to Dr K Srinath Reddy, president, Public Health Foundation of India, on his views about the new variant. While vaccines are expected to provide us some degree of protection, Reddy said the government’s policy on the booster dose of vaccine will depend on vulnerability and priorities